Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ELAN compared with GSK: revenue, margins and what each company keeps, and the suppliers and customers both name
ELAN
Elanco Animal Health Inc
Change
Mkt cap
Revenue
Revenue
GSK
GSK plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ELAN
Elanco Animal Health Inc
vs
GSK
GSK plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ELAN
2 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±9.4%
▲
+8.70%
×0.93
Q2 FY26
—
▲
+2.42%
—
GSK
No earnings history for GSK.
= implied
ELAN realized, solid
GSK realized, hatched
One scale, both sides: full bar = 10%
× = |realized| ÷ implied
Source: market data
ELAN
Elanco Animal Health Inc
Change
25.72
▲
+8.61%
· post 26.02
Mkt cap
$12.9B
Revenue
$1.3B
Q3 FY26
Revenue
$4.7B
FY25
GSK
GSK plc
Change
50.31
▼
−0.20%
· post 50.31
Closed
Nov 6 '26
Mkt cap
$108.6B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
ELAN
Elanco Animal Health Inc
vs
GSK
GSK plc
25.72
▲
+8.61%
post 26.02
Price
50.31
▼
−0.20%
post 50.31
$12.9B
Mkt cap
$108.6B
Q3 FY26
$1.3B
Revenue
—
FY25
$4.7B
Revenue
—
Change
Change
ELAN
25.72
▲
+8.61%
vs
GSK
50.31
▼
−0.20%
Closed
Nov 6 '26